Basel HCD Panel: The future of Clinical Trials
Do., 27. März
|Team Meeting (cf. link below)
The event will feature an engaging and insightful discussion on clinical trial challenges, focusing on inclusion, diversity, and real-world data enablement, with contributions from industry experts and thought leaders. This event is also a pilot supporting the creation of the 2025 HCD White Paper.
Time & Location
27. März 2025, 18:30 – 19:30
Team Meeting (cf. link below)
Guests
About the event
Join us for an enlightening event on March 27th at 18:30 CET , where industry experts and leaders will address the complexities of Randomized Clinical Trials (RTCs).
This discussion will delve into critical challenges such as improving inclusion and diversity, enhancing the use of real-world data (RWD), and integrating technologies like AI for trial enablement. Attendees will gain insights into why RTCs often face high failure rates and explore strategies for overcoming low recruitment and resistance to change.
The event will tackle pivotal questions around utilizing secondary healthcare data and addressing social determinants of health globally. Our expert HCD panelists will also discuss the evolving role of principal investigators and study teams, the impact of market reimbursement strategies on global access to new medications, and ways to mitigate the high-risk nature of RTCs.